Glutathione depletion occurs in Aids as a direct effect of the virus. it is also common in other chronic viral infections. These patients dont develop ME .
I have been saying this for some time (that AIDS patients do not develop ME/CFS). But yes, glutathione depletion may have varying levels of severity, and there may be other co-factors for developing ME/CFS.
Retroviruses can directly interfere with DNA methylation and directly reduce glutathione in these instances these observations are an effect rather than a cause.
The cause which sets off this chain of events in this scenario is a retroviral infection.
The majority of patients recieve little or no benefit .with the glutathione treatment protocol why? because something is continually and actively depleting the glutathione levels.
An inserted retrovirus acting as a pseudogene or affecting gene regulation would be consistent with this observation
If low glutathione is causative then replacement should theoretically eliminate the symptoms and we have a problem with accounting for other reported observations as well
This is also something I have tried to say repeatedly, but there is more. The lowered glutathione sets the stage for continued viral and probably also any retroviral activation. Then toxins build up, eventually blocking glutathione production itself. So the effect becomes the cause, it creates a vicious cycle. The major point we are differing on in this context is that I believe herpes activation alone can cause this scenario, if it coincides with some other preconditions (perhaps enterovirus) and is able to activate a HERV such as K18.
Yes a retrovirus is one possible factor in glutathione/methylation cycle problems, if its pseudogene activity targeted some critical step in the methylation cycle. However, if that were the case then more than likely everyone infected with that retrovirus would go on to develop CFS.
Actually a majority of CFS patients using methylation support experienced some benefit, per the study reported at the Reno conference. Several who used methylation support in conjunction with other therapies recovered enough to return to work. I believe that is critical, to address the factors depleting the glauthione along with the methylation cycle problem itself. So I agree completely that if the gluathione explanation is correct then understanding the glutathione load and reducing that is critical. Maybe even more important than directly treating the broken methylation cycle. And a retrovirus as part of glutathione load makes more sense to me than direct interference in the cycle. If a retrovirus interfered directly then all infected would contract CFS. Whereas , if a retrovirus is just part of glutathione load then those with SNPs in the methylation cycle would be more affected, most carriers would not be sick. Anyway why not treat the whole pathology, both reduce glutathione load dramatically, lowering oxidative stress, and also support the SNPs with the 'genetic bypass' approach promoted by Yasko and Rich VanK. That is what those who are recovered may have done in Rich's study.
Also, if ME/CFS is a glutathione overload condition (meaning too much load on glutathione production), then there may be many diverse load factors and triggers, more than just one virus or retrovirus, which is consistent with experience of this disease. Retroviruses for some, herpes reactivation for some, multiple co-infections, trauma, chronic stress in a person with pain/fatigue receptor vulnerabilities, all types of possibilities for that load.
Just supplementing glutathione does not always help because that is a large molecule that is hard to absorb. Also I believe in some cases it must be produced inside human cells, and it has some rate limiting production factors so increasing levels is complicated. Thus the need to 'unblock' the methylation cycle problems to get cells to produce their own glutathione again and stop the continual mitochondria damage from the oxidative stress.
Note that increasing cellular glutathione improves survival chances in AIDS, and slows viral replication. We could argue about the reasons, I suspect it helps by slowing co-infection activity, but maybe it also slows retroviral activity. If XMRV is proven to be part of the CFS pathology I also suspect that glutathione/methylation cycle support will be one of the preferred treatments due to relative safety and inability of ART to significantly alter disease course in a slow replicator retrovirus. However, apparently the unique SNPs of CFS patients MUST be taken into account, so just going to an alt med doc and saying you need to boost glutathion may be counterproductive, as most docs do not know about the common sulfur processing problems and the complex liver detox issues most of us have. So some program like Rich's approach may make a lot of sense, combined with adjunct treatments that can help reduce total glutathione load.